H
Power Law company profile
Harbour BioMed
Biotech & Life Sciences · Cambridge, United States · Founded 2016 · IPO 2020 Thoroughbred
Valuation
$1.01B
Market cap · May/2026
Revenue
$158M
Latest reported FY
EBITDA
$95M
Latest reported FY
Featured in
$10B+ revenueThoroughbred · Power Law outcome
Global footprint
Where Harbour BioMed has talent and traffic
Workforce by country
6
countries with
team presence
team presence
🇨🇳 China76.7%
🇺🇸 United States18.6%
🇭🇰 Hong Kong1.5%
🇸🇬 Singapore1.3%
🇬🇧 United Kingdom1.3%
Web traffic by country
6.3K
monthly visits
across markets
across markets
🇺🇸 United States65.1%
🇮🇳 India15.9%
🇨🇦 Canada12.7%
🇯🇵 Japan4.8%
🇭🇰 Hong Kong1.6%
Market sentiment
What the market is saying about Harbour BioMed
An AI-synthesized read of the highest-engagement posts about Harbour BioMed on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Harbour BioMed on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.